These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35087068)

  • 1. Viral immune evasins impact antigen presentation by allele-specific trapping of MHC I at the peptide-loading complex.
    Sethumadhavan S; Barth M; Spaapen RM; Schmidt C; Trowitzsch S; Tampé R
    Sci Rep; 2022 Jan; 12(1):1516. PubMed ID: 35087068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation.
    Brunnberg J; Barends M; Frühschulz S; Winter C; Battin C; de Wet B; Cole DK; Steinberger P; Tampé R
    Proc Natl Acad Sci U S A; 2024 May; 121(22):e2321600121. PubMed ID: 38771881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing.
    Hulpke S; Baldauf C; Tampé R
    FASEB J; 2012 Dec; 26(12):5071-80. PubMed ID: 22923333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.
    Aladin F; Lautscham G; Humphries E; Coulson J; Blake N
    Cancer Immunol Immunother; 2007 Aug; 56(8):1143-52. PubMed ID: 17143611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
    Raafat N; Sadowski-Cron C; Mengus C; Heberer M; Spagnoli GC; Zajac P
    Int J Cancer; 2012 Sep; 131(5):E659-69. PubMed ID: 22116674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes.
    Oosten LE; Koppers-Lalic D; Blokland E; Mulder A; Ressing ME; Mutis T; van Halteren AG; Wiertz EJ; Goulmy E
    Int Immunol; 2007 Sep; 19(9):1115-22. PubMed ID: 17855435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selected HLA-B allotypes are resistant to inhibition or deficiency of the transporter associated with antigen processing (TAP).
    Geng J; Zaitouna AJ; Raghavan M
    PLoS Pathog; 2018 Jul; 14(7):e1007171. PubMed ID: 29995954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47.
    Jugovic P; Hill AM; Tomazin R; Ploegh H; Johnson DC
    J Virol; 1998 Jun; 72(6):5076-84. PubMed ID: 9573278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the structure of the MHC class I peptide-loading complex and mechanisms of TAP inhibition by viral immune evasion proteins.
    Praest P; Liaci AM; Förster F; Wiertz EJHJ
    Mol Immunol; 2019 Sep; 113():103-114. PubMed ID: 29606337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.
    Pande NT; Powers C; Ahn K; Früh K
    J Virol; 2005 May; 79(9):5786-98. PubMed ID: 15827193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of the localization and function of the human cytomegalovirus protein US6 on the transporter associated with antigen processing.
    Dugan GE; Hewitt EW
    J Gen Virol; 2009 Sep; 90(Pt 9):2234-8. PubMed ID: 19439551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An annular lipid belt is essential for allosteric coupling and viral inhibition of the antigen translocation complex TAP (transporter associated with antigen processing).
    Eggensperger S; Fisette O; Parcej D; Schäfer LV; Tampé R
    J Biol Chem; 2014 Nov; 289(48):33098-108. PubMed ID: 25305015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
    Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
    J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other.
    Said A; Azab W; Damiani A; Osterrieder N
    J Virol; 2012 Aug; 86(15):8059-71. PubMed ID: 22623773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-Mediated Inhibition of the Transporter Associated with Antigen Processing Is Insufficient To Induce Major Histocompatibility Complex E-Restricted CD8
    Abdulhaqq SA; Wu H; Schell JB; Hammond KB; Reed JS; Legasse AW; Axthelm MK; Park BS; Asokan A; Früh K; Hansen SG; Picker LJ; Sacha JB
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the human MHC-I peptide-loading complex.
    Blees A; Januliene D; Hofmann T; Koller N; Schmidt C; Trowitzsch S; Moeller A; Tampé R
    Nature; 2017 Nov; 551(7681):525-528. PubMed ID: 29107940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8 T cell-evasive functions of human cytomegalovirus display pervasive MHC allele specificity, complementarity, and cooperativity.
    Ameres S; Besold K; Plachter B; Moosmann A
    J Immunol; 2014 Jun; 192(12):5894-905. PubMed ID: 24808364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
    Johnson DC; Hegde NR
    Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous TAP-independent MHC-I antigen presentation: not just the ER lumen.
    Del Val M; Antón LC; Ramos M; Muñoz-Abad V; Campos-Sánchez E
    Curr Opin Immunol; 2020 Jun; 64():9-14. PubMed ID: 31935516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Flow Cytometry-Based Approach to Unravel Viral Interference with the MHC Class I Antigen Processing and Presentation Pathway.
    Praest P; de Buhr H; Wiertz EJHJ
    Methods Mol Biol; 2019; 1988():187-198. PubMed ID: 31147941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.